Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radiochemotherapy. Radiation therapy. Antibody therapy. Radioimmunotherapy. 2. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Polycythemia vera Pain in bony metastases Medullary thyroid carcinoma Dyspnea in lung Ca 3. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Salvage therapy. Retreatment. Standard therapy. Consolidation therapy. 4. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Myelosuppression Leukemia Radiation pneumonitis Gastritis 5. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Arrhythmia Fever Anemia Bruising 6. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 6 months. With the birth of another child. Never. After 3 months. 7. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propylthiouracil Metronidazole and Propranolol Methimazole and Propylthiouracil Methimazole and Propranolol 8. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Blocking thyroid uptake of free radioiodine Performing pulmonary function tests 9. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Super phenomenon. Flare scan. Super scan. Flare phenomenon. 10. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should urinate frequently Patient should use antiperspirant medications Patient laxatives Patient should be well hydrated 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| Share This Post With Others! FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave a ReplyCancel reply
Leave a Reply